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S90 Am J PCigarettes are the greatest single threat to publichealth in the U.S.1 and worldwide.2 The goodnews is that teen cigarette smoking has been
trending down in recent years.3 The bad news is that
teen use of other tobacco products may be taking up
the slack.
This is very bad news–and it comes despite the
momentum of the past decade when researchers learned
much about how and why youth try cigarettes, how
quickly they show signs of addiction, how hard it is for
them to quit, how insidious and effective tobacco
marketing remains,4 and how effective policies can
reduce youth smoking.
Many in the tobacco-control community were encour-
aged by the news that the U.S. Food and Drug Admin-
istration (FDA) was regulating cigarettes and smokeless
tobacco. The FDA could now constrain marketing for
cigarettes even more, impose packaging restrictions,
including bigger and better warning labels, require
companies to list all the ingredients in their products,
and even regulate the manufacturing of the product,
including nicotine content.
Unfortunately, cigarette and smokeless companies were
also encouraged by the news—enough to respond with a
massive output of more than 3,000 substantially equivalent
products—new brands that they claim are little different
from products that were already on the market before
2007. Additionally, companies that produce non-regulated
products have ﬁlled voids created by FDA regulations. For
example, cigar manufacturers have responded to FDA
cigarette ﬂavor restrictions with a ﬂood of ﬂavored little
and medium cigars. Additionally, a new potentially
reduced risk product has emerged—the electronic or
e-cigarette.5 Being unregulated, e-cigarettes have rapidly
gained a foothold in the U.S. market.6 Companies are
promoting e-cigarettes using mass media, includingrris Cotton Cancer Center, Geisel School of Medicine at
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out. The question this FDA/CDC research collaboration
seeks to ask is, what are the implications of all these new
products on youth tobacco use? The answers are just
beginning to emerge, and it appears that the impact of
these new products on youth behavior is profound—youth
are using them all, some more than others.
New Tobacco Product Use Among Teens—
A Big Research Gap
Until recently, researchers have focused almost exclusively
on cigarette smoking. This research has taught us many
things, among them: (1) some youth—those who are poor,9
whose social networks are characterized by high smoking
rates,10,11 and whose personality is characterized by
sensation-seeking12,13 and deviance tolerance14—begin
experimenting in early adolescence, and these youth tend
to be at high risk for many other risk behaviors15; (2)
smoking is not limited to these high-risk youth—the onset
of smoking among middle- and upper-class youth con-
tinues through young adulthood in workplace and college
settings16; (3) some youth exhibit symptoms of addiction
soon after smoking onset, and well prior to regular use17,18;
(4) many youth tobacco users report wanting to quit and
trying but failing to succeed19–21; and (5) exposure to
tobacco marketing is one cause of youth smoking.4
This American Journal of Preventive Medicine supple-
ment highlights new work addressing the use of
expanded cigarette and other tobacco products by youth
in an era of FDA regulation. It reports results from the
2012 National Youth Tobacco Survey of almost 25,000
U.S. middle and high school students.
The articles in the supplement conﬁrm some things
that we already know. For example, about half of current
youth tobacco users have tried to quit using in the past
year, and quitting intentions vary little by product used.
Adolescents remain curious about tobacco products, and
curiosity is associated with their recollection of seeing
tobacco marketing. Finally, despite restrictions in the
marketing of tobacco products, adolescents—especially
users—remain susceptible to marketing. For example,
use of tobacco coupons was only 13% overall but 30%
among current tobacco users.rican Journal of Preventive Medicine  Published by Elsevier Inc.
Sargent / Am J Prev Med 2014;47(2S1):S90–S92 S91The supplement also tells us a lot that is new. The
survey was modiﬁed to include many forms of tobacco
in the market today. The survey found that about half of
respondents were aware of new tobacco products, with
substantial rates of ever and current use of e-cigarettes
(7% and 2%, respectively); hookah (9% and 4%); and
cigars (21% and 8%). Many of the surveyed adolescents
were using multiple products, as evidenced by the fact
that use of alternative products was much higher among
cigarette users. There were also notable racial and ethnic
differences in prevalence; for example, current cigar use
was much higher among non-Hispanic blacks, among
whom cigar smoking greatly exceeded cigarette
smoking.
Perhaps most importantly, the survey looked at use of
e-cigarettes. The key question with youth is whether
e-cigarettes will recruit youth that would not have
otherwise tried tobacco because of the perceived health
risks (90% of youth perceived daily smoking to be very
harmful to health)—youth that may transition to using
combustible products once they become addicted to
nicotine.
The survey found that use of e-cigarettes alone was
uncommon, but those who did use them perceived them
to be lower risk than using cigarettes. These perceptions
are not surprising; after all, some tobacco researchers see
e-cigarettes as a potential game changer that could
dramatically reduce health risk among combustible
tobacco users.22 Theoretically, combustible tobacco users
could substantially reduce their risk only through exclu-
sive use of e-cigarettes; instead, most current users
consume e-cigarettes in addition to combustible pro-
ducts, a practice that may have little impact on harm
caused by combustible tobacco.
FDA Oversight of the Tobacco Industry—
A Big Regulatory Gap
The goal of the Family Smoking Prevention and
Tobacco Control Act was, in part, to “ensure that the
FDA has the authority to address issues of particular
concern to public health ofﬁcials, especially the use of
tobacco by young people and dependence on tobacco.”
To date, the agency has moved very cautiously in
implementing regulations, much too slow to keep up
with an industry that has responded with thousands of
novel products and even new classes of products. The
recently launched youth anti-tobacco campaign is a
welcome FDA action, rolling out a national media
campaign that emphasizes short-term health conse-
quences and loss of self-control implied by nicotine
addiction. Raising perceptions of immediate harm
could lower youth experimentation. However, theseAugust 2014ads cover only cigarettes and smokeless tobacco. This
supplement underlines that, in order to substantially
affect tobacco use, the FDA will have to succeed in
regulating other products that they will soon have
authority over—hookah, e-cigarettes, and cigars. The
million-dollar question is whether the very deliberative
FDA bureaucracy, designed primarily to regulate drug
development, will be able to move fast enough to
effectively capture and regulate the rapidly evolving
tobacco industry.
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